Navigation Links
Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the company's ability to control or predict. Important factors that may cause actual results to differ materially and could impact the company and the statements contained in this news release can be found in the company's filings with the Securities and Exchange Commission, including quarterly reports on Form 10-Q, current reports on Form 8-K and annual reports on Form 10-K. For forward-looking statements in this news release, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

About Bristol-Myers Squibb

Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With expertise, dedication and resolve, that vision led to the development of a diverse global portfolio of anti-cancer therapies that are an important cornerstone of care today. Hundreds of scientists at Bristol-Myers Squibb's Pharmaceutical Research Institute are studying ways to improve current cancer treatments and identify better, more effective medicines for the future.

Bristol-Myers Squibb is a global pharmaceutica
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... (CAS 103-90-2) Market Research Report 2014" report to ... Market Research Report 2014 presents comprehensive data on paracetamol ... , Asia , North ... includes paracetamol (acetaminophen) description, covers its application areas and ...
(Date:9/15/2014)... 15, 2014  MedExpress Urgent Care, a national leader in ... flu shots for ages four and up at each of ... get their flu shot early. According to ... of June, making late summer and early fall an ideal ... Vice President of Provider and Clinical Quality, Thomas Pangburn ...
(Date:9/15/2014)... PLYMOUTH MEETING, Pa. , Sept. 15, 2014 /PRNewswire/ ... today that it has met the stringent listing criteria ... has transferred to this U.S. stock exchange from the ... its current ticker symbol, "INO." NASDAQ ... Market, maintains the highest initial listing standards of any ...
Breaking Medicine Technology:Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3
... TOPAZ Technologies, a leading provider of biomedical research ... ML Weekes & Company, a professional services firm ... strategic partnership.  As a result of this partnership, ... solution through ML Weekes & Company,s RAMS grantsERA ...
... Texas, Nov. 16, 2010 Argon Medical Devices, Inc. ... licensing agreement with Rex Medical, LP ("Rex Medical") for ... dialysis catheter ™ on a global basis. UltraStream ™ ... patients receiving dialysis treatments. Argon will be ...
Cached Medicine Technology:TOPAZ Technologies and ML Weekes & Company Announce Partnership 2TOPAZ Technologies and ML Weekes & Company Announce Partnership 3Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream™' Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... Spings, OH (PRWEB) September 16, 2014 ... Master of Arts in Clinical Mental Health Counseling ... joins a growing list of programs offered through Antioch’s ... spring semester starting January 2015. , "Antioch University New ... strong reputation in the field and a track record ...
(Date:9/16/2014)... QuickMedical, a national leader in the ... veteran-owned small business has officially launched three new ... Nipro Medical, and CP Medical Sutures. , ... best, most affordable medical equipment and supplies. To ... effort to reach new medical facilities, QuickMedical has ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 The ... of Virginia this fall. Reflecting on what it means ... Expanding Community Vision investigates unique and thought-provoking topics. , ... to be inspired to look at their world differently. ... and set the stage for truly enlightening dialogue,” says ...
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 Today, ... Annual Action Icon Awards to be held, Sunday, October ... Los Angeles. The annual awards show honors the ... actresses and extreme sports stars. Over 12 categories ... hosted by ESPN’s Kenny Mayne. , Special honors ...
(Date:9/16/2014)... September 16, 2014 Triad Semiconductor, Inc. ... CEO of Intersil and former President of Linear Technology ... , “David has extraordinary technology and business expertise, and ... of directors,” said Lynn Hayden, Triad CEO and chairman. ... analog and mixed signal semiconductor experience to Triad's board. ...
Breaking Medicine News(10 mins):Health News:Antioch University Launches Online Master’s Degree Program in Clinical Mental Health Counseling 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2
... use vitamin supplements for good health despite the fact that ... argues that the best way to stay healthy is a ... because they're worried that food has fewer nutrients than it ... and minerals is freshly picked produce, reported the online edition ...
... will be served at the domestic theme parks of the ... sign movie// and other endorsement deals only with restaurants that ... ,Disney will put the new guidelines into practice ... of 2007, the trans-fats will be completely removed from the ...
... lung disease; Chronic Obstructive Pulmonary Disease (COPD) will affect ... ,Chronic bronchitis and emphysema constitute COPD, which is ... fatigue, shortness of breath and subsequent difficulty in breathing ... at the Hvidovre Hospital in Denmark conducted a 25-year ...
... new study by researchers at Northwestern University has revealed a ... a U.S. regional poison control// center from 2001 through 2004, ... years. , ,Lead researcher Danielle McCarthy said “This study ... abuse. Part of the problem is that people do not ...
... child’s susceptibility to autism is increased with a single gene ... ,This discovery has far-reaching implications because this gene, a ... specifically a brain gene but rather a gene which has ... immune function and gut repair. ,Therefore researchers have ...
... Palmieri, of Imperial College London, on a small group of ... of Vitamin D with the progression of breast cancer to ... of circulating Vitamin D could play a significant role in ... tests of the women who underwent the study have shown ...
Cached Medicine News:Health News:Madhya Pradesh Tops in Implementing Child Health Scheme 2Health News:Risk of Autism doubled with Single Gene Mutation 2
... custom bars have a large body ... contacts (spaced 3 centimeters center-to-center) to ... repeated cleaning. Polarity indicators are molded ... handle fits our bar electrode styles. ...
... phakic IOL is the first lens of its ... for the reduction or elimination of myopia in ... diopters and in patients aged 21 and over. ... 150,000 procedures performed worldwide, results prove that the ...
... the strongest vacuum force in ... The unit includes a ... plug, footswitch, built-in wheels, retractable ... ring to hold the liquid ...
... technology for the phakic eye, clinically ... quality of vision and visual acuity ... lens is compatible with current cataract ... for the correction of myopia in ...
Medicine Products: